Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.74 |
| ▸ | GSK3A | P49840 | 6/20 | 0.74 |
| ▸ | GSK3B | P49841 | 6/20 | 0.74 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | ELANE | P08246 | 2/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | PLG | P00747 | 1/20 | 0.55 |
| ▸ | CTSG | P08311 | 1/20 | 0.55 |
| ▸ | CMA1 | P23946 | 1/20 | 0.55 |
| ▸ | CTRC | Q99895 | 1/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.47 |
| ▸ | ALDH3A1 | P30838 | 2/20 | 0.47 |
| ▸ | RGS4 | P49798 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14286721 | 0.88 | MGLL (0.75) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL25435490 | 0.86 | MGLL (1.00) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL207740 | 0.86 | MGLL (1.00) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL17532637 | 0.85 | MGLL (0.58) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL13033718 | 0.81 | MGLL (0.59) | MGLLGSK3AGSK3BFAAHPTGS1 | |
| SCHEMBL19075842 | 0.81 | GSK3A (0.76) | MGLLGSK3AGSK3BFAAHCASP3 | |
| SCHEMBL28874121 | 0.79 | MGLL (0.78) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL12993174 | 0.78 | MGLL (0.53) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL29091080 | 0.76 | MGLL (0.78) | MGLLGSK3AGSK3BFAAHELANE | |
| SCHEMBL22320218 | 0.74 | MGLL (1.00) | MGLLGSK3AGSK3BFAAHELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479799-B2 | Bioconjugation reagent and methods | UNIVERSITEIT GENT (BE) | 2025-11-25 | — | — | US | disclosed |
| US-20220169604-A1 | BIOCONJUGATION REAGENT AND METHODS | UNIVERSITEIT GENT (BE) | 2022-06-02 | — | — | US | disclosed |
| US-9938272-B2 | Hydrazine compound as blood coagulation factor Xa inhibitor | NORTH CHINA PHARMACEUTICAL COMPANY., LTD. (CN) | 2018-04-10 | — | — | US | disclosed |
| US-20170152259-A1 | HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR | NORTH CHINA PHARMACEUTICAL COMPANY., LTD. (CN) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152259-A1 | HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR | F12, F10, F11 | MGLL 3934/4885GSK3A 2237/4885GSK3B 1837/4885 |
| US-20220169604-A1 | BIOCONJUGATION REAGENT AND METHODS | PIGS, MACF1, PTMA | MGLL 1426/4885GSK3A 1727/4885GSK3B 1646/4885 |
| US-12479799-B2 | Bioconjugation reagent and methods | PIGS, MACF1, PTMA | MGLL 1426/4885GSK3A 1727/4885GSK3B 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.